- Company Overview for ASN PHARMA LTD (NI682487)
- Filing history for ASN PHARMA LTD (NI682487)
- People for ASN PHARMA LTD (NI682487)
- More for ASN PHARMA LTD (NI682487)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
19 Sep 2024 | CS01 | Confirmation statement made on 19 September 2024 with updates | |
31 Jul 2024 | AA | Total exemption full accounts made up to 31 October 2023 | |
18 Apr 2024 | PSC07 | Cessation of Colm James Kerr as a person with significant control on 18 April 2024 | |
18 Apr 2024 | PSC04 | Change of details for Mr Andrew Fitzpatrick as a person with significant control on 18 April 2024 | |
18 Apr 2024 | SH01 |
Statement of capital following an allotment of shares on 18 April 2024
|
|
20 Sep 2023 | AA | Total exemption full accounts made up to 31 October 2022 | |
19 Sep 2023 | CS01 | Confirmation statement made on 19 September 2023 with no updates | |
20 Sep 2022 | CS01 | Confirmation statement made on 19 September 2022 with no updates | |
12 Sep 2022 | AD01 | Registered office address changed from Suite 1 Fountain Centre College Street Belfast BT1 6ET United Kingdom to 98-102 Donegall House 2nd Floor Donegall Street Belfast BT1 2GW on 12 September 2022 | |
21 Dec 2021 | AA01 | Current accounting period extended from 30 September 2022 to 31 October 2022 | |
29 Sep 2021 | PSC04 | Change of details for Mr Andrew Fitzpatrick as a person with significant control on 20 September 2021 | |
29 Sep 2021 | CH01 | Director's details changed for Mr Andrew Fitzpatrick on 20 September 2021 | |
20 Sep 2021 | NEWINC |
Incorporation
Statement of capital on 2021-09-20
|